|
Volumn 113, Issue 5, 2009, Pages 1203-1204
|
Elevated expression of the leukemia-associated antigen SSX2IP predicts survival in acute myeloid leukemia patients who lack detectable cytogenetic rearrangements
|
Author keywords
[No Author keywords available]
|
Indexed keywords
LEUKEMIA ANTIGEN;
LEUKEMIA ASSOCIATED ANTIGEN SSX2IP;
UNCLASSIFIED DRUG;
EPITOPE;
PEPTIDE;
RNA;
TUMOR ANTIGEN;
ACUTE GRANULOCYTIC LEUKEMIA;
ANTIGEN EXPRESSION;
CANCER SURVIVAL;
CHROMOSOME ANALYSIS;
CHROMOSOME REARRANGEMENT;
CORRELATION COEFFICIENT;
GENE EXPRESSION;
KAPLAN MEIER METHOD;
KARYOTYPE;
LETTER;
MICROARRAY ANALYSIS;
PRIORITY JOURNAL;
PROGNOSIS;
SURVIVAL RATE;
SURVIVAL TIME;
ANIMAL;
CELL STRAIN COS1;
CELL STRAIN HL 60;
CELL STRAIN K 562;
CERCOPITHECUS;
DISEASE FREE SURVIVAL;
FEMALE;
GENE EXPRESSION REGULATION;
GENETICS;
HUMAN;
IMMUNOLOGY;
IMMUNOTHERAPY;
MALE;
METHODOLOGY;
NOTE;
PATHOLOGY;
ANIMALS;
ANTIGENS, NEOPLASM;
CERCOPITHECUS AETHIOPS;
COS CELLS;
DISEASE-FREE SURVIVAL;
EPITOPES;
FEMALE;
GENE EXPRESSION REGULATION, LEUKEMIC;
HL-60 CELLS;
HUMANS;
IMMUNOTHERAPY;
K562 CELLS;
LEUKEMIA, MYELOID, ACUTE;
MALE;
PEPTIDES;
PROGNOSIS;
RNA, NEOPLASM;
SURVIVAL RATE;
|
EID: 60849083533
PISSN: 00064971
EISSN: 15280020
Source Type: Journal
DOI: 10.1182/blood-2008-09-178848 Document Type: Letter |
Times cited : (26)
|
References (7)
|